Timothy Stenzel has been spending his time helping lead development of new companion diagnostics and next-generation sequencing panels. Now he will be the point person for regulating these products in
Company Changes BLANCHARD , Cheryl R., PhD To: Microchips Biotech Inc. , CEO (July) From: Zimmer Holdings Inc., SVP, CSO Phone: 781-275-1445 CERIO , Michael C. To: Signal Genetics Inc. , S
Company Changes New At The Helm This Month AGARWAL , Sunil, MD To: Ultragenyx Pharmaceutical Inc. , SVP, CMO (August) From: Genentech Inc., SVP, Global Head, Clinical Dev., Immunology & Infectio
IN VITRO DIAGNOSTICS Asuragen Inc. Series D round brings $15mm to Asuragen Asuragen Inc. (mRNA- and miRNA-based molecular diagnostics for cancer and genetic diseases) raised $15mm from 15 undi